Compare Berkshire Hathaway Inc Class B (BRK.B) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Berkshire Hathaway Inc Class B vs GSK plc — how do they compare? Berkshire Hathaway Inc Class B trades at $489.53, while GSK plc trades at $51.23 (market cap $101.55B). The key difference: GSK plc pays a 3.5% dividend while Berkshire Hathaway Inc Class B pays none. Which is the better fit depends on your goals.
| BRK.B | GSK | |
|---|---|---|
Sector | Financials | Health |
52-Week High | $513.70 | $61.18 |
52-Week Low | $459.10 | $36.20 |
Market Cap | — | $101.55B |
Enterprise Value | — | $122.16B |
Dividend Yield | — | 3.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BRK.B trades at $488.81, down 1.61% today, with a bullish technical signal from moving averages but neutral oscillators. Support levels are near $487-$494, while resistance sits at $500-$507. Analyst consensus is positive with 57% buy ratings, though key valuation ratios like P/E and P/B are not provided in the snapshot. The stock's technical setup suggests potential for near-term stability if support holds.
The outlook for BRK.B hinges on Berkshire Hathaway's diversified business performance and market sentiment. Risks include economic cycles impacting its holdings, while opportunities lie in its strong cash flow and acquisition strategy. Investors should weigh analyst optimism against broader market volatility.
GSK trades at $52.29, down 0.93% with neutral technical signals. The company shows strong fundamentals with Q1 2026 EPS beating expectations at $1.24 versus $1.16 forecast. Recent FDA approvals for Utebzi and positive Jemperli trial results highlight pipeline strength. Valuation metrics appear reasonable with P/E of 13.94 and ROE of 36.42%.
GSK presents a balanced investment case with solid profitability and promising drug pipeline offset by mixed analyst sentiment and competitive pressures. The stock offers income potential with 3.46% dividend yield but faces execution risks in drug development and market competition.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Berkshire Hathaway Inc Class B
Berkshire Hathaway is a holding company with diverse subsidiaries, primarily in insurance through Geico and its reinsurance groups. It reinvests profits into various industries, owning Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy, and major manufacturing, service, and retail businesses like Precision Castparts and Lubrizol. The company operates in a highly decentralized manner.
Read more on BRK.B →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
